Skip to main content
Top
Published in: Clinical Rheumatology 3/2007

01-03-2007 | Original Article

Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study

Authors: Shih-Yang Chen, Ching-Lang Chen, Ming-Lai Shen

Published in: Clinical Rheumatology | Issue 3/2007

Login to get access

Abstract

To examine whether serum urate level and other aspects of gouty arthritis are independently associated with Q-wave myocardial infarction (QWMI) in gouty population, we performed a cross-sectional study. A total of 22,572 gouty cases were enrolled. QWMI was defined as a positive finding by resting electrocardiographic criteria excluding the conditions producing pseudoinfarction. The variables of gout were tested univariately and multivariately, controlling for the covariates by logistic regression analysis. The above analysis was then repeated in subgroups of young-aged (<50 years), old-aged (≧50 years), male, and female patients. Increased serum urate level was significantly associated with QWMI in all subjects and male subgroup [odds ratio (OR), 1.120; 95% confidence interval (CI), 1.020–1.229; OR, 1.106; 95% CI, 1.001–1.223, respectively, for each mg/dl increment]. After controlling for serum urate level and the covariates, increased affected joint count was also independently associated with QWMI finding in all subjects, male and old-aged subgroups (OR, 1.098; 95% CI, 1.014–1.189; OR, 1.094; 95% CI, 1.005–1.192; OR, 1.095; 95% CI, 1.001–1.199, respectively). Tophi formation was independently associated with QWMI in young-aged subgroup (OR, 2.494; 95% CI, 1.159–5.366). None of the variables of gout including hyperuricemia was significantly associated with QWMI in female subgroup after controlling for covariates. This study first demonstrates that gout is associated with QWMI by both the severity of gouty arthritis and serum urate level, while the association of urate to QWMI could be different between age strata and genders.
Literature
1.
go back to reference Chang HY, Pan WH, Yeh WT, Tsai KS (2001) Hyperuricaemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol 28(7):1640–1646PubMed Chang HY, Pan WH, Yeh WT, Tsai KS (2001) Hyperuricaemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol 28(7):1640–1646PubMed
2.
go back to reference Wortmann RL, Kelley WN (2001) Gout and hyperuricemia. In: Ruddy S, Harris ED Jr, Sledge CB (eds) Kelley’s textbook of rheumatology, 6th edn. Saunders, Philadelphia, PA, pp 1339–1376 Wortmann RL, Kelley WN (2001) Gout and hyperuricemia. In: Ruddy S, Harris ED Jr, Sledge CB (eds) Kelley’s textbook of rheumatology, 6th edn. Saunders, Philadelphia, PA, pp 1339–1376
3.
go back to reference Brand FN, McGee DL, Kannel WB et al (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121(1):11–18PubMed Brand FN, McGee DL, Kannel WB et al (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121(1):11–18PubMed
4.
go back to reference Freedman DS, Williamson DF, Gunter EW et al (1995) Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 141:637–644PubMed Freedman DS, Williamson DF, Gunter EW et al (1995) Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 141:637–644PubMed
5.
go back to reference Culleton BF, Larson MG, Kannel WB et al (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 131:7–13PubMed Culleton BF, Larson MG, Kannel WB et al (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 131:7–13PubMed
6.
go back to reference Tweddale MG, Fodor JG (1979) Elevated serum uric acid: a cardiovascular risk factor. Nephron 23:3 Tweddale MG, Fodor JG (1979) Elevated serum uric acid: a cardiovascular risk factor. Nephron 23:3
7.
go back to reference Fessel WJ (1980) High uric acid as an indicator of cardiovascular disease, independence from obesity. Am J Med 68:401PubMedCrossRef Fessel WJ (1980) High uric acid as an indicator of cardiovascular disease, independence from obesity. Am J Med 68:401PubMedCrossRef
8.
go back to reference Johnson MW, Mitch WE (1981) The risks of asymptomatic hyperuricemia and the use of uricosuric diuretics. Drugs 21:220PubMed Johnson MW, Mitch WE (1981) The risks of asymptomatic hyperuricemia and the use of uricosuric diuretics. Drugs 21:220PubMed
9.
go back to reference Alderman MH, Cohen H, Madhavan S et al (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34:144–150PubMed Alderman MH, Cohen H, Madhavan S et al (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34:144–150PubMed
10.
go back to reference Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA 283:2404–2410PubMedCrossRef Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA 283:2404–2410PubMedCrossRef
11.
go back to reference Verdecchia P, Schillaci G, Reboldi G et al (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 36:1072–1078PubMed Verdecchia P, Schillaci G, Reboldi G et al (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 36:1072–1078PubMed
12.
go back to reference Wang J-G, Staessen JA, Fagard RH et al (2001) Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37:1069–1074PubMed Wang J-G, Staessen JA, Fagard RH et al (2001) Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37:1069–1074PubMed
13.
go back to reference Wallace SL, Robinson H, Masi AT et al (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895–900PubMed Wallace SL, Robinson H, Masi AT et al (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895–900PubMed
14.
go back to reference Goldschlager N, Goldman MJ (1984) Electrocardiography: essentials of interpretation. Lange Medical Publications, California Goldschlager N, Goldman MJ (1984) Electrocardiography: essentials of interpretation. Lange Medical Publications, California
15.
go back to reference Taussig AS (1983) Misleading ECGs: patterns of infarction. J Cardiovasc Med 1:561 Taussig AS (1983) Misleading ECGs: patterns of infarction. J Cardiovasc Med 1:561
16.
go back to reference Denke M, Wilson JD (1998) Assessment of nutritional status. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds) Harrison’s principles of internal medicine, 14th edn. McGraw-Hill, New York, pp 448–452 Denke M, Wilson JD (1998) Assessment of nutritional status. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds) Harrison’s principles of internal medicine, 14th edn. McGraw-Hill, New York, pp 448–452
17.
go back to reference 1988 Joint National Committee (1988) The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 148:1023–1038CrossRef 1988 Joint National Committee (1988) The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 148:1023–1038CrossRef
18.
go back to reference American Diabetes Association (2002) Standards of medical care for patients with diabetes mellitus. Diabetes Care 25(1):213–229 American Diabetes Association (2002) Standards of medical care for patients with diabetes mellitus. Diabetes Care 25(1):213–229
19.
go back to reference Abbott RD, Brand FN, Kannel WB et al (1988) Gout and coronary heart disease: the Framingham study. J Clin Epidemiol 41(3):237–242PubMedCrossRef Abbott RD, Brand FN, Kannel WB et al (1988) Gout and coronary heart disease: the Framingham study. J Clin Epidemiol 41(3):237–242PubMedCrossRef
20.
go back to reference Sudbo J, Lee JJ, Lippman SM et al (2005) Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet 366(9494):1359–1366PubMedCrossRef Sudbo J, Lee JJ, Lippman SM et al (2005) Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet 366(9494):1359–1366PubMedCrossRef
21.
go back to reference Kanellis J, Watanabe S, Li JH et al (2002) The evidence for a functional organic anion transporter in vascular smooth muscle cells. In: American Society of Nephrology 35th Annual Meeting and Scientific Exposition, Philadelphia, Pa, 30 Oct–4 Nov 2002, 13:329A Kanellis J, Watanabe S, Li JH et al (2002) The evidence for a functional organic anion transporter in vascular smooth muscle cells. In: American Society of Nephrology 35th Annual Meeting and Scientific Exposition, Philadelphia, Pa, 30 Oct–4 Nov 2002, 13:329A
22.
go back to reference Johnson RJ, Kang D-H, Feig D et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190PubMedCrossRef Johnson RJ, Kang D-H, Feig D et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190PubMedCrossRef
23.
go back to reference Ginsberg MH, Kozin F, O’Malley M et al (1977) Release of platelet constituents by monosodium urate crystals. J Clin Invest 60:999–1007PubMed Ginsberg MH, Kozin F, O’Malley M et al (1977) Release of platelet constituents by monosodium urate crystals. J Clin Invest 60:999–1007PubMed
24.
go back to reference Ginsberg M, Henson P, Henson J et al (1979) Mechanisms of platelet response to monosodium urate crystals. Am J Pathol 94(3):549–568PubMed Ginsberg M, Henson P, Henson J et al (1979) Mechanisms of platelet response to monosodium urate crystals. Am J Pathol 94(3):549–568PubMed
25.
go back to reference Boogaerts MA, Hammerschmidt ED, Roelant C et al (1983) Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost 50(2):576–580PubMed Boogaerts MA, Hammerschmidt ED, Roelant C et al (1983) Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost 50(2):576–580PubMed
26.
go back to reference Palella TD, Fox IH (1989) Hyperuricemia and gout. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, p 965 Palella TD, Fox IH (1989) Hyperuricemia and gout. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, p 965
27.
go back to reference Ridker PM, Genest J, Libby P (2001) Risk factors for atherosclerotic disease. In: Braunwald E, Zipes DP, Libby P (eds) Heart disease: a textbook of cardiovascular medicine, 6th edn. Saunders, Philadelphia, PA, pp 1010–1039 Ridker PM, Genest J, Libby P (2001) Risk factors for atherosclerotic disease. In: Braunwald E, Zipes DP, Libby P (eds) Heart disease: a textbook of cardiovascular medicine, 6th edn. Saunders, Philadelphia, PA, pp 1010–1039
28.
go back to reference Gelber AC, Klag MJ, Mead LA et al (1997) Gout and risk for subsequent coronary heart disease: the Meharry–Hopkins study. Arch Intern Med 157:1436–1440PubMedCrossRef Gelber AC, Klag MJ, Mead LA et al (1997) Gout and risk for subsequent coronary heart disease: the Meharry–Hopkins study. Arch Intern Med 157:1436–1440PubMedCrossRef
29.
go back to reference Lally EV, Ho G Jr, Kaplan SR (1986) The clinical spectrum of gouty arthritis in women. Arch Intern Med 146:2221–2225PubMedCrossRef Lally EV, Ho G Jr, Kaplan SR (1986) The clinical spectrum of gouty arthritis in women. Arch Intern Med 146:2221–2225PubMedCrossRef
30.
go back to reference Puig JG, Michan AD, Jimenez ML et al (1991) Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 151:726–732PubMedCrossRef Puig JG, Michan AD, Jimenez ML et al (1991) Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 151:726–732PubMedCrossRef
Metadata
Title
Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study
Authors
Shih-Yang Chen
Ching-Lang Chen
Ming-Lai Shen
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0292-4

Other articles of this Issue 3/2007

Clinical Rheumatology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.